200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 288-37-9
288-37-9 | 1,2,5-oxadiazole
CAS No: 288-37-9 Catalog No: AG002WK7 MDL No:
Product Description
Catalog Number:
AG002WK7
Chemical Name:
1,2,5-oxadiazole
CAS Number:
288-37-9
Molecular Formula:
C2H2N2O
Molecular Weight:
70.0501
IUPAC Name:
1,2,5-oxadiazole
InChI:
InChI=1S/C2H2N2O/c1-2-4-5-3-1/h1-2H
InChI Key:
JKFAIQOWCVVSKC-UHFFFAOYSA-N
SMILES:
c1cnon1
NSC Number:
111891
Properties
Complexity:
26.8
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
70.017g/mol
Formal Charge:
0
Heavy Atom Count:
5
Hydrogen Bond Acceptor Count:
3
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
70.051g/mol
Monoisotopic Mass:
70.017g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
38.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.2
Literature
| Title | Journal |
|---|---|
| Characterization of nitrogen-bridged 1,2,4,5-tetrazine-, furazan-, and 1H-tetrazole-based polyheterocyclic compounds: heats of formation, thermal stability, and detonation properties. | Journal of molecular modeling 20120801 |
| The influence of the substitution pattern on the molecular conformation of ureido-1,2,5-oxadiazoles, related to STAT3 inhibitors: chemical behavior and structural investigation. | Chemistry & biodiversity 20120701 |
| Synthesis and biological evaluation of novel furozan-based nitric oxide-releasing derivatives of oridonin as potential anti-tumor agents. | Molecules (Basel, Switzerland) 20120618 |
| 4-[4-(4-Amino-1,2,5-oxadiazol-3-yl)-1,2,5-oxadiazol-3-yl]-1,2,5-oxadiazol-3-amine. | Acta crystallographica. Section E, Structure reports online 20120501 |
| 4,9,12,15-Tetra-oxa-3,5,8,10,14,16-hexa-aza-tetra-cyclo-[11.3.0.0.0]hexa-deca-1(16),2,5,7,10,13-hexaen-3-ium-3-olate monohydrate. | Acta crystallographica. Section E, Structure reports online 20120301 |
| [Soluble guanylate cyclase in the molecular mechanism underlying the therapeutic action of drugs]. | Biomeditsinskaia khimiia 20120101 |
| Equilibrium structures of heterocyclic molecules with large principal axis rotations upon isotopic substitution. | The journal of physical chemistry. A 20111208 |
| Copper(II)-mediated oxidative transformation of vic-dioxime to furoxan: evidence for a copper(II)-dinitrosoalkene intermediate. | Inorganic chemistry 20111121 |
| Genetic toxicology and preliminary in vivo studies of nitric oxide donor tocopherol analogs as potential new class of antiatherogenic agents. | Drug and chemical toxicology 20110701 |
| Amodiaquine analogues containing NO-donor substructures: synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria. | European journal of medicinal chemistry 20110501 |
| Surface-enhanced fluorescence and surface-enhanced Raman scattering of push-pull molecules: sulfur-functionalized 4-amino-7-nitrobenzofurazan adsorbed on Ag and Au nanostructured substrates. | Analytical and bioanalytical chemistry 20110401 |
| Furoxan nitric oxide donor coupled chrysin derivatives: synthesis and vasculoprotection. | Bioorganic & medicinal chemistry letters 20110215 |
| 1,2,5-Oxadiazole analogues of leflunomide and related compounds. | European journal of medicinal chemistry 20110101 |
| Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents. | Bioorganic & medicinal chemistry letters 20101115 |
| Thermal decomposition of 3,4-bis(4'-aminofurazano-3') furoxan. | Journal of hazardous materials 20100515 |
| Synthesis and evaluation of nitric oxide-releasing derivatives of farnesylthiosalicylic acid as anti-tumor agents. | Bioorganic & medicinal chemistry 20100515 |
| Synthesis and structure-activity relationships of novel furazan-3,4-diamide analogs as potent anti-cancer agents. | Bioorganic & medicinal chemistry letters 20100201 |
| Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. | Current medicinal chemistry 20100101 |
| Structural modifications of quinoline-based antimalarial agents: Recent developments. | Journal of pharmacy & bioallied sciences 20100101 |
| Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis. | Journal of medicinal chemistry 20091022 |
| Dimerisation of nitrile oxides: a quantum-chemical study. | Physical chemistry chemical physics : PCCP 20090714 |
| Furazan-functionalized tetrazolate-based salts: a new family of insensitive energetic materials. | Chemistry (Weinheim an der Bergstrasse, Germany) 20090302 |
| Synthesis and promotion angiogenesis effect of chrysin derivatives coupled to NO donors. | Bioorganic & medicinal chemistry letters 20090215 |
| Synthesis, spectroscopy and structure of the parent furoxan (HCNO)2. | The journal of physical chemistry. A 20090108 |
| Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies. | Bioorganic & medicinal chemistry 20080901 |
| Hydroxy-1,2,5-oxadiazolyl moiety as bioisoster of the carboxy function. A computational study on gamma-aminobutyric acid (GABA) related compounds. | Journal of molecular modeling 20080401 |
| Drug discovery: schistosome treatment. | Nature 20080320 |
| 3,4-Bis(4-nitro-phen-yl)-1,2,5-oxadiazole 2-oxide. | Acta crystallographica. Section E, Structure reports online 20080201 |
| Excited electronic state decomposition of furazan based energetic materials: 3,3'-diamino-4,4'-azoxyfurazan and its model systems, diaminofurazan and furazan. | The Journal of chemical physics 20080121 |
| A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages. | Journal of inflammation (London, England) 20080101 |
| Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans. | Journal of medicinal chemistry 20071004 |
| Application of multicomponent reactions to antimalarial drug discovery. Part 3: discovery of aminoxazole 4-aminoquinolines with potent antiplasmodial activity in vitro. | Bioorganic & medicinal chemistry letters 20070901 |
| Efficient configuration selection scheme for vibrational second-order perturbation theory. | The Journal of chemical physics 20070721 |
| Synthesis and antimalarial activities of some furoxan sulfones and related furazans. | European journal of medicinal chemistry 20051201 |
| Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives. | Bioorganic & medicinal chemistry 20050801 |
| (1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: further optimisation as highly potent and selective MSK-1-inhibitors. | Bioorganic & medicinal chemistry letters 20050715 |
| Synthesis and cytotoxic evaluation of combretafurazans. | Journal of medicinal chemistry 20050505 |
| Non-imidazole histamine NO-donor H3-antagonists. | Farmaco (Societa chimica italiana : 1989) 20050101 |
| Efficient calculation of potential energy surfaces for the generation of vibrational wave functions. | The Journal of chemical physics 20041115 |
| Synthesis, characterization and thermal studies on furazan- and tetrazine-based high energy materials. | Journal of hazardous materials 20040910 |
| Difurazano[3,4-b:3',4'-f]-4,5-diaza-1,8-dioxacyclododecine and an acyclic analogue. | Acta crystallographica. Section C, Crystal structure communications 20040701 |
| [3-(1H-imidazol-4-yl)propyl]guanidines containing furoxan moieties: a new class of H3-antagonists endowed with NO-donor properties. | Bioorganic & medicinal chemistry 20030403 |
| H3 receptor ligands: new imidazole H3-antagonists endowed with NO-donor properties. | Farmaco (Societa chimica italiana : 1989) 20030301 |
| Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin. | Journal of medicinal chemistry 20030227 |
| High throughput assay for cytochrome P450 BM3 for screening libraries of substrates and combinatorial mutants. | Biosensors & bioelectronics 20020101 |
| 1,2,5-Oxadiazole N-oxide derivatives as potential anti-cancer agents: synthesis and biological evaluation. Part IV. | European journal of medicinal chemistry 20011001 |
| [Formations and reactions of aromatic furazan compounds]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20010601 |
| Studies on agents with mixed NO-dependent and calcium channel antagonistic vasodilating activities. | Pharmaceutical research 20010201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.